Link Pharma Chem Peer Comparison

BSE: 524748

₹24.10

₹0.07 (0.29%)

As on 04-Nov-2026 14:52IST

Market cap

₹11 Cr

Revenue (TTM)

₹27 Cr

P/E Ratio

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Market cap (₹ Cr)	11	44,679	8,133	3,904	3,986
Revenue (₹ Cr)	27	4,066	1,760	650	2,785
Net Profit (₹ Cr)	-0.24	910.57	247.43	62.92	284.68
Net Margin (%)	-0.88	21.94	13.78	9.59	10.17
RoE (%)	-1.90	21.72	15.59	8.01	12.42
Price to Earnings	--	49.07	32.87	62.05	13.99
Price-To-Book	0.85	10.01	4.95	4.79	1.69

Income Statement (₹ Cr)

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Operating Revenue	27.42	4,065.90	1,759.87	649.85	2,784.63
Total Income	27.66	4,149.76	1,796.22	655.77	2,799.54
Total Expenditure	26.32	2,672.66	1,390.73	523.26	2,198.00
EBITDA	1.11	1,393.24	369.14	126.60	586.63
Depreciation	1.05	161.83	71.35	40.18	171.57
EBIT	0.06	1,231.41	297.79	86.42	415.06
Interest	0.56	118.04	1.36	6.72	44.75
Other Income	0.24	83.86	36.35	5.92	14.91
Exceptional Items	0.00	-6.75	0.00	-1.32	0.00
Profit before Tax	-0.26	1,190.48	332.78	84.30	385.22
Provision for Tax	-0.01	279.91	85.35	21.38	100.54
Profit after Tax	-0.24	910.57	247.43	62.92	284.68

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Shareholder's Funds	12.90	4,462.34	1,641.61	814.65	2,364.69
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.91	1,342.40	177.86	8.55	508.47
Current Liabilities	7.40	1,025.85	214.93	295.53	712.16
Total Liabilities	24.96	6,846.40	2,184.82	1,003.69	3,505.30

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Non-Current Assets	12.10	3,659.81	1,118.00	614.26	2,588.31
Current Assets	8.77	3,002.90	832.16	468.83	964.56
Total Assets	24.96	6,846.40	2,184.82	1,003.69	3,505.30
Total Debt*	7.30	1,226.35	0.00	120.37	562.99
Net Current Assets	1.37	1,977.05	617.23	173.30	252.40
Contingent Liabilities	1.61	8.87	34.13	11.68	84.66

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Cash From Operating Activities	2.15	893.57	238.55	31.49	435.53
Cash Flow from Investing Activities	-2.66	-1,234.91	-137.10	-115.84	-354.67
Cash from Financing Activities	0.99	344.21	-56.08	78.93	-94.48
Net Cash Inflow / Outflow	0.48	2.87	45.37	-5.42	-13.62

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
ROCE (%)	3.45	21.39	16.65	7.17	15.65
ROE (%)	-1.90	21.72	15.59	8.01	12.42
ROA (%)	-1.04	14.60	13.02	6.21	8.35
EBIT Margin (%)	0.22	30.29	16.92	13.30	14.91
Net Margin (%)	-0.88	21.94	13.78	9.59	10.17
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Revenue Growth (%)	5.89	45.68	13.38	49.69	12.89
EBIT Growth (%)	167.82	91.71	39.38	270.07	-17.14
Net Profit Growth (%)	59.40	105.03	35.83	254.75	-29.20
EPS Growth (%)	59.40	101.67	35.81	260.37	-29.21
Book Value Growth (%)	1.00	52.04	9.27	5.81	16.64

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Price / Earnings	-43.73	47.76	34.36	59.89	13.82
Price / Book Value	0.81	9.82	5.24	4.70	1.67
Dividend Yield (%)	0.00	0.18	0.60	0.12	0.55
EV/EBITDA	15.67	31.37	22.35	31.12	7.66
Market Cap (₹ Cr)	10.06	31,554.29	6,297.94	2,458.27	3,492.31

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Debt to Equity	0.04	0.20	0.01	0.01	0.12
Short term debt to equity ratio	0.49	0.05	--	0.15	0.05
Current Ratio	1.19	2.93	3.87	1.59	1.35
Quick Ratio	0.41	2.51	2.91	0.74	0.84
Interest Coverage	0.54	11.09	245.69	13.54	9.61

	Link Pharma Chem	Navin Fluorine	Alkyl Amines	Tatva Chintan	Epigral
Debtors to sales (%)	8.40	21.87	17.52	27.45	14.23
Asset Turnover	1.17	0.65	0.93	0.64	0.82
Receivable days	68.51	73.48	54.80	75.16	44.32
Inventory Days	71.58	42.29	34.09	118.92	50.32
Payable days	114.34	116.22	76.04	73.91	56.85
Cash Conversion Cycle	25.75	-0.45	12.85	120.17	37.79

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.